Agios Pharmaceuticals, Inc. (AGIO)
Agios Pharmaceuticals Market Cap : 1.780B for Feb. 24, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Dynavax Technologies Corp. (DELISTED) | 1.820B |
| Gilead Sciences, Inc. | 183.14B |
| CorMedix, Inc. | 557.04M |
| Alnylam Pharmaceuticals, Inc. | 44.11B |
| Enanta Pharmaceuticals, Inc. | 427.89M |
Market Cap Related Metrics
| PS Ratio | 32.59 |
| Price to Book Value | 1.492 |
| Price | 30.38 |
| Earnings Yield | -23.43% |